The role of quetiapine in the treatment of bipolar disorder

No abstract is available for this paper.

• Publication year

  2006

• Venue

  Expert Opinion on Pharmacotherapy

• Publication date

  2006-04-24

• Fields of study

  Medicine

• Identifiers
  DOI 10.1517/14656566.7.7.929PMID 16634715
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Extrapyramidal side effects with atypical neuroleptics in bipolar disorder.

  2006cited by this paper
• Seroquel: biochemical profile of a potential atypical antipsychotic

  2005influential reference
• Olanzapine versus lithium in the maintenance treatment of bipolar disorder: a 12-month, randomized, double-blind, controlled clinical trial.

  2005cited by this paper
• Effectiveness of aripiprazole v. haloperidol in acute bipolar mania: double-blind, randomised, comparative 12-week trial.

  2005cited by this paper
• Managing Bipolar Disorder in the Elderly

  2005cited by this paper
• A randomized, double-blind, placebo-controlled efficacy and safety study of quetiapine or lithium as monotherapy for mania in bipolar disorder.

  2005cited by this paper
• A randomized, double-blind, placebo-controlled trial of quetiapine in the treatment of bipolar I or II depression.

  2005cited by this paper
• Quetiapine or haloperidol as monotherapy for bipolar mania--a 12-week, double-blind, randomised, parallel-group, placebo-controlled trial.

  2005cited by this paper
• Quetiapine monotherapy for mania associated with bipolar disorder: combined analysis of two international, double-blind, randomised, placebo-controlled studies

  2005cited by this paper
• Combination quetiapine therapy in the long-term treatment of patients with bipolar I disorder

  2005cited by this paper
• Comparison of fluoxetine, olanzapine, and combined fluoxetine plus olanzapine initial therapy of bipolar type I and type II major depression--lack of manic induction.

  2005influential reference
• Long-term treatment of adjunctive quetiapine for bipolar mania.

  2005cited by this paper
• Pharmacokinetics of Quetiapine in Elderly Patients with Selected Psychotic Disorders

  2004cited by this paper
• Use of quetiapine in bipolar disorder: a case series with prospective evaluation.

  2004cited by this paper
• Quetiapine with lithium or divalproex for the treatment of bipolar mania: a randomized, double-blind, placebo-controlled study.

  2004cited by this paper
• Quetiapine Versus Placebo in Combination With Lithium or Divalproex for the Treatment of Bipolar Mania

  2004cited by this paper
• Cocaine and Amphetamine Use in Patients With Psychiatric Illness: A Randomized Trial of Typical Antipsychotic Continuation or Discontinuation

  2003cited by this paper
• Aripiprazole in the treatment of schizophrenia: safety and tolerability in short-term, placebo-controlled trials.

  2003cited by this paper
• Quetiapine as adjunctive treatment of a case of rapid‐cycling bipolar disorder with comorbidity

  2003cited by this paper
• Use of higher-dose quetiapine in elderly inpatients: A chart review study

  2003cited by this paper
• Adjunctive quetiapine in bipolar patients partially responsive to lithium or valproate.

  2003cited by this paper
• Vascular risk factors in late onset mania

  2002cited by this paper
• What role do atypical antipsychotic drugs have in treatment-resistant depression?

  2002cited by this paper
• Efficacy of olanzapine in combination with valproate or lithium in the treatment of mania in patients partially nonresponsive to valproate or lithium monotherapy.

  2002cited by this paper
• Quetiapine in bipolar disorder and cocaine dependence.

  2002cited by this paper
• Efficacy of quetiapine and risperidone against depressive symptoms in outpatients with psychosis.

  2002cited by this paper
• Risperidone in the treatment of mania: efficacy and safety results from a large, multicentre, open study in Spain.

  2002cited by this paper
• A double-blind, randomized, placebo-controlled study of quetiapine as adjunctive treatment for adolescent mania.

  2002cited by this paper
• Quetiapine in the treatment of rapid cycling bipolar disorder.

  2002cited by this paper
• Combination of a mood stabilizer with risperidone or haloperidol for treatment of acute mania: a double-blind, placebo-controlled comparison of efficacy and safety.

  2002cited by this paper
• The Stanley Foundation Bipolar Treatment Outcome Network. I. Longitudinal methodology.

  2001cited by this paper
• Drug abuse and bipolar disorder: comorbidity or misdiagnosis?

  2001cited by this paper
• Quetiapine treatment of rapid-cycling bipolar disorder: An open prospective study

  2001cited by this paper
• The Stanley Foundation Bipolar Treatment Outcome Network. II. Demographics and illness characteristics of the first 261 patients.

  2001cited by this paper
• Quetiapine as a mood stabilizer in bipolar disorder

  2001cited by this paper
• Quetiapine alone and added to a mood stabilizer for serious mood disorders.

  2001cited by this paper
• The Expert Consensus Guideline Series: Medication Treatment of Bipolar Disorder 2000.

  2000cited by this paper
• Clinical Experience with Quetiapine in Elderly Patients with Psychotic Disorders

  2000cited by this paper
• Clozapine in the treatment of refractory psychotic mania.

  2000cited by this paper
• Quetiapine for treatment-resistant mania.

  2000cited by this paper
• Significant interaction between clozapine and cocaine in cocaine addicts.

  2000cited by this paper
• Long-Term use of quetiapine in elderly patients with psychotic disorders.

  2000cited by this paper
• Efficacy of olanzapine in acute bipolar mania: a double-blind, placebo-controlled study. The Olanzipine HGGW Study Group.

  2000cited by this paper
• The effects of clozapine on alcohol and drug use disorders among patients with schizophrenia.

  2000cited by this paper
• The impact of substance abuse on the course of bipolar disorder.

  2000cited by this paper
• Atypical Antipsychotics in the Treatment of Bipolar Disorder

  2000cited by this paper
• Bipolar Disorder in the Elderly

  2000cited by this paper
• Epidemiology, etiology, and treatment of geriatric mania.

  2000cited by this paper
• Pharmacokinetics, tolerability, and clinical effectiveness of quetiapine fumarate: an open-label trial in adolescents with psychotic disorders.

  2000cited by this paper
• The Use of Quetiapine for Treatment-Resistant Bipolar Disorder

  2000cited by this paper
• Olanzapine versus placebo in the treatment of acute mania. Olanzapine HGEH Study Group.

  1999cited by this paper
• Clinical practice guidelines for bipolar disorder from the Department of Veterans Affairs.

  1999cited by this paper
• Molecular properties of brain sodium channels: an important target for anticonvulsant drugs.

  1999cited by this paper
• Use of atypical antipsychotic agents in bipolar and schizoaffective disorders: review of the empirical literature.

  1999cited by this paper
• Ziprasidone 80 mg/day and 160 mg/day in the Acute Exacerbation of Schizophrenia and Schizoaffective Disorder: A 6-Week Placebo-Controlled Trial

  1999cited by this paper
• Quetiapine, a novel antipsychotic: experience in elderly patients with psychotic disorders. Seroquel Trial 48 Study Group.

  1999cited by this paper
• The use of quetiapine for treatment-resistant bipolar disorder: a case series.

  1999cited by this paper
• Use of atypical antipsychotic agents in bipolar and schizoaffective disorders: review of the empirical literature.

  1999cited by this paper
• Mood stabilizer combinations: a review of safety and efficacy.

  1998cited by this paper
• Clinical predictors of acute response with olanzapine in psychotic mood disorders.

  1998cited by this paper
• Olanzapine versus placebo in the treatment of acute mania

  1998cited by this paper
• Clinical predictors of acute response with quetiapine in psychotic mood disorders.

  1998cited by this paper
• Acute Treatment of Bipolar Disorder with Adjunctive Risperidone in Outpatients

  1997cited by this paper
• Sodium channels and therapy of central nervous system diseases.

  1997cited by this paper
• The epidemiology of DSM-III-R bipolar I disorder in a general population survey

  1997cited by this paper
• A neuroendocrine role in cocaine reinforcement.

  1997cited by this paper
• Multiple fixed doses of "Seroquel" (quetiapine) in patients with acute exacerbation of schizophrenia: a comparison with haloperidol and placebo. The Seroquel Trial 13 Study Group.

  1997cited by this paper
• Manic-Depressive Illness and Substance Abuse

  1997cited by this paper
• Mood Stabilizers: Shared Mechanisms of Action at Postsynaptic Signal‐Transduction and Kindling Processes

  1996cited by this paper
• Relationship between concurrent substance abuse in psychiatric patients and neuroleptic dosage.

  1995cited by this paper
• Schizophrenia and psychostimulant abuse: a review and re-analysis of clinical evidence

  1995cited by this paper
• The spectrum of depressive phenomena after spousal bereavement.

  1994cited by this paper
• Extrapyramidal side effects and tolerability of risperidone: a review.

  1994cited by this paper
• Practice guideline for the treatment of patients with bipolar disorder. American Psychiatric Association.

  1994cited by this paper
• Gerald L. Kierman, M.D., 1928-1992

  1994cited by this paper
• Affective disorders in five United States communities

  1988cited by this paper
• Persistent tardive dyskinesia in bipolar patients.

  1986cited by this paper
• Amish Study, I: Affective disorders among the Amish, 1976-1980.

  1983influential reference
• Dr. Egeland and Dr. Hostetter Reply

  1983cited by this paper
• MANIC DEPRESSIVE ILLNESS

  1970cited by this paper

• Abordaje clínico y terapéutico del Trastorno Bipolar en España: una encuesta nacional.

  2025cites this paper
• Mood Stabilizers of First and Second Generation

  2023cites this paper
• Toxicological and histopathological findings in a suicidal quetiapine overdose

  2021cites this paper
• The Black Book of Psychotropic Dosing and Monitoring.

  2018cites this paper
• New therapeutic strategy for mood disorders.

  2011cites this paper
• Quetiapine-Induced Hyperventilation and Dyspnea

  2010cites this paper
• Quetiapine monotherapy in bipolar I disorder: A 1-year stabilization in a woman having undergone bone marrow transplantation

  2010cites this paper
• Adjunctive antidepressant treatment with quetiapine in agitated depression: positive effects on symptom reduction, psychopathology and remission rates

  2008cites this paper
• Real-world use of quetiapine in early psychosis: An acute inpatient and community follow-up effectiveness study

  2008cites this paper
• Quetiapine monotherapy in bipolar disorder: Two years maintenance treatment in an elderly woman.

  2008cites this paper
• (quetiapine) in patients with acute exacerbation of schizophrenia: a comparison

  2008cites this paper
• Use of a two-way communication questionnaire in antipsychotic therapy: an analysis of two observational studies on differences in understanding of individual patient needs between physicians and patients treated with quetiapine fumarate (Seroquel ®) Utilité du questionnaire 2-COM dans la thérapie

  2008cites this paper
• 2-COM dans la thérapie antipsychotique: analyse de deux études sur les différences de compréhension entre médecin et patient concernant les besoins du patient sous traitement par fumarate de quétiapine (Seroquel ®)

  2008cites this paper
• Atypical antipsychotics in the treatment of mood disorders

  2007cites this paper
• Effects of adjunctive antidepressant therapy with quetiapine on clinical outcome, quality of sleep and daytime motor activity in patients with treatment‐resistant depression

  2007cites this paper
• Quetiapine indication shift in the elderly: diagnosis and dosage in 208 psychogeriatric patients from 2000 to 2006

  2007cites this paper
• Pharmacoeconomics of quetiapine for the management of acute mania in bipolar I disorder

  2007cites this paper